Starpharma Holdings Limited is engaged in the development of dendrimer products which is a type of synthetic nanoscale polymer. It is used for pharmaceutical, life science and other applications. Starpharma’s programs include development of DEP drug delivery and VivaGel portfolio.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK